Skip to main content
. 2014 Sep;53(5):485–493.

Table 1.

Effects of analgesics on parameters related to thrombosis

No analgesia Bupivacaine Buprenorphine Tramadol Carprofen
Vein wall leukocytes (no. of cells/high-power field)
 6 h
  Neutrophils 12.0; 5.5–24.5 ↓ 8.0; 2.0–15.8 ↑ 8.0; 1.5–31.5 ↓ 5.5; 1.0–11.5 ↓ 4.5; 1.0–8.5
  Macrophages 1.0; 0.0–1.0 ↑ 1.0; 0.0–2.0 1.0; 0.0–1.0 ↓ 0.0; 0.0–1.0 ↑ 0.0; 0.0–2.0
  Lymphocytes 1.0; 0.0–2.0 1.0; 0.0–2.0 ↑ 1.0; 0.0–2.5 ↑ 1.0; 0.5–3.0 ↑ 1.0; 0.0–3.0
 48 h
  Neutrophils 14.5; 8.0–17.5 ↑ 14.0; 4.3–21.8 ↓ 11.0; 7.0–19.3 ↑ 18.0; 9.5–44.0 ↓ 7.0; 3.0–11.5
  Macrophages 3.0; 2.0–4.0 ↓ 2.0; 1.0–3.0 ↓ 2.0; 1.0–2.5 ↓ 2.0; 1.0–3.0 ↓ 1.5; 1.0–3.0
  Lymphocytes 3.0; 1.0–4.0 2.0; 1.0–3.5 2.0; 2.0–3.0 2.0; 1.0–3.0 3.0; 2.0–4.0
Vein wall cytokines (pg/μg protein)
 6 h
  IL1β 18.9 ± 3.4 ↑ 18.9 ± 4.3 ↑ 20.1 ± 4.8 ↑ 20.0 ± 5.8 ↑ 22.4 ± 7.2
  IL6 4059.5 ± 545.9 ↑ 4106.6 ± 850.7 ↑ 5446.5 ± 1061.8 ↑ 10066.9 ± 3144.7 ↓ 3395.2 ± 682.2
  IL10 32.8 ± 7.0 ↓ 17.2 ± 2.4 ↓ 30.9 ± 3.7 ↑ 62.4 ± 19.9 ↓ 31.4 ± 5.6
 48 h
  IL1β 14.0 ± 3.4 ↑ 16.3 ± 3.9 ↑ 18.4 ± 2.8 ↓ 11.5 ± 2.2 ↑ 20.7 ± 5.1
  IL6 596.5 ± 79.6 ↓ 330.6 ± 45.3 ↓ 449.6 ± 100.4 ↓ 444.0 ± 53.9 ↓ 249.1 ± 64.0
  IL10 20.4; 14.1–31.6 ↓ 13.1; 10.1–20.1 ↑ 17.7; 7.1–49.8 ↓ 10.9; 9.2–26.0 ↓ 13.0; 9.3–19.5
Circulating IL6 (pg/μg protein)
 6 h 21.6 ± 4.6 ↓ 17.2 ± 2.4 ↓ 11.5 ± 1.6 ↓ 11.7 ± 2.4 ↓ 9.7 ± 1.7
 48 h 1.2; 1.0–1.4 ↑ 2.1; 1.1–2.9 ↑ 1.6; 1.2–3.8 ↑ 2.6; 1.4–4.2 ↑ 1.1; 0.7–1.9
CBC (× 103 cells/μL)
 6 h
  WBC 4.42; 3.22–4.83 ↓ 4.02; 3.23–4.69 ↑ 4.75; 3.51–6.33 ↓ 3.82; 2.46–4.31 ↑ 5.22; 4.79–5.41
  Neutrophils 3.04; 2.40–3.58 ↑ 2.82; 2.09–3.44 ↑ 3.45; 2.68–4.65 ↑ 2.03; 1.82–3.15 ↑ 3.72; 3.58–4.01
  Lymphocytes 0.92; 0.67–1.20 ↑ 0.88; 0.68–1.26 ↑ 1.13; 0.71–1.43 ↓ 1.03; 0.53–1.22 ↑ 1.22; 0.96–1.70
  Monocytes 0.11; 0.10–0.20 ↑ 0.17; 0.11–0.32 ↑ 0.12; 0.05–0.19 ↓ 0.07; 0.06–0.08 ↓ 0.17; 0.11–0.29
  Platelets 626; 576–659 ↑ 683; 604–835 ↑ 620; 572–722 ↓ 478; 347–730 ↑ 671; 635–708
 48 h
  WBC 4.16; 2.45–4.80 ↑ 6.34; 3.88–6.74 ↓ 2.82; 2.06–4.21 ↓ 3.24; 2.21–3.95 ↓ 3.12; 2.50–4.80
  Neutrophils 1.76; 1.25–1.86 ↑ 3.09; 1.70–3.64 ↓ 1.54; 1.07–2.05 ↓ 1.14; 0.90–1.51 ↓ 1.03; 0.76–1.55
  Lymphocytes 2.20; 1.15–2.89 ↑ 2.60; 2.09–3.21 ↓ 1.25; 0.93–2.04 ↓ 1.82; 1.12–2.07 ↑ 1.89; 1.56–2.95
  Monocytes 0.08; 0.05–0.10 ↓ 0.07; 0.06–0.09 ↓ 0.05; 0.04–0.11 ↑ 0.28; 0.12–0.37 ↑ 0.23; 0.13–0.27
  Platelets 359; 281–485 ↑ 430; 367–549 ↑ 484; 411–626 ↓ 324; 277–364 ↓ 307; 295–337
Hct (%)
 6 h 38.4; 38.2–38.8 ↑ 39.6; 38.6–41.5 38.8; 37.9–40.8 ↓ 38.7; 35.2–40.9 ↑ 42.1; 38.5–44.3
 48 h 36.2; 35.3–39.4 ↓ 34.1; 31.6–35.8 ↓ 31.6; 31.0–33.6 ↓ 31.0; 27.4–34.2 ↓ 36.9; 35.0–37.1
Soluble P-selectin (pg/μg protein)
 6 h 6.13; 5.90–7.67 ↓ 5.78; 5.35–6.09 ↑ 9.95; 6.62–10.90 ↑ 8.47; 7.80–10.31 ↑ 7.22; 6.29–7.73
 48 h 9.98; 8.94–11.39 ↑ 11.99; 8.84–12.23 ↑ 9.76; 8.43–13.11 ↑ 13.63; 10.16–13.88 ↓ 9.73; 9.31–10.89
Thrombus weight (mg)
 6 h 13.1 ± 0.7 ↑ 17.6 ± 1.4 ↑ 13.9 ± 1.5 ↑ 15.6 ± 1.2 ↓ 12.3 ± 4.2
 48 h 30.5 ± 1.2 ↓ 27.6 ± 1.3 ↓ 27.5 ± 1.3 ↓ 26.7 ± 1.3 ↓ 26.6 ± 1.1

Results reported as mean ± SEM for parametric data and median and interquartile range for nonparametric data. Bold text indicates values that are significantly (P < 0.05) different from that of the no-analgesia group.